Bionano Genomics, Inc. (NASDAQ:BNGO) Receives $7.00 Consensus PT from Analysts
Bionano Genomics, Inc. (NASDAQ:BNGO – Get Free Report) has earned a consensus recommendation of “Hold” from the four analysts that are covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average twelve-month price target among analysts that […]
Bionano Genomics, Inc. (NASDAQ:BNGO – Get Free Report) has earned a consensus recommendation of “Hold” from the four analysts that are covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average twelve-month price target among analysts that […]
